Doyle L W, Gultom E, Chuang S L, James M, Davis P, Bowman E
Division of Paediatrics, Royal Women's Hospital, Carlton, Victoria, Australia.
J Paediatr Child Health. 1999 Jun;35(3):255-9. doi: 10.1046/j.1440-1754.1999.00349.x.
To contrast the mortality rates and changes in the causes of death of very preterm infants (23-27 weeks), before and after the introduction of exogenous surfactant in 1991, and to identify any preventable causes of death remaining in the 1990s.
This was a cohort study on consecutive preterm infants of 23-27 weeks' gestational age born in the Royal Women's Hospital, Melbourne, a level III perinatal centre. The infants were livebirths free of lethal anomalies from two distinct eras, 1983-90, and 1992-96, inclusive. The main outcome measures were mortality during the primary hospitalization and the causes of death before and after the introduction of exogenous surfactant in 1991.
In 1983-90, 261 of 508 livebirths (51.4%) of 23-27 weeks' gestational age died, a significantly higher proportion than the 109 of 384 (28.4%) livebirths who died in the period 1992-96. The mortality rate fell significantly with increasing gestational age and was lower at each week of gestational age in 1992-96. More infants who died in 1992-96 were treated intensively in the neonatal intensive care unit (NICU). Of the group of infants who died or who were treated intensively in NICU, respiratory causes of death predominated. However, the causes of death changed over time. In 1992-96 proportionally fewer infants died from respiratory causes (1983-90, 82.5%; 1992-96, 60.0%; odds ratio (OR) 0.31, 95%; confidence interval (CI) 0.16-0.57), but more from septic causes (1983-90, 14.3%; 1992-96, 43.8%; OR 4.9, 95%; CI 2.6-9.2).
As the mortality rate has fallen over time, respiratory causes of death have diminished, but septic causes of death have increased. Further advances in the use of exogenous surfactant and respiratory support may reduce respiratory deaths. Effective strategies to reduce nosocomial infections are urgently required.
对比1991年外源性表面活性剂引入前后,极早产儿(23 - 27周)的死亡率及死亡原因变化,并确定20世纪90年代仍存在的任何可预防的死亡原因。
这是一项队列研究,研究对象为墨尔本皇家妇女医院(一家三级围产期中心)连续出生的孕龄23 - 27周的早产儿。这些婴儿为1983 - 1990年和1992 - 1996年(含)这两个不同时期的活产儿,且无致命畸形。主要观察指标为初次住院期间的死亡率以及1991年引入外源性表面活性剂前后的死亡原因。
在1983 - 1990年,508例孕龄23 - 27周的活产儿中有261例(51.4%)死亡,这一比例显著高于1992 - 1996年384例活产儿中的109例(28.4%)。死亡率随孕龄增加而显著下降,且在1992 - 1996年每个孕龄周的死亡率都更低。1992 - 1996年死亡的婴儿中,更多在新生儿重症监护病房(NICU)接受了强化治疗。在死亡或在NICU接受强化治疗的婴儿组中,呼吸原因导致的死亡占主导。然而,死亡原因随时间发生了变化。1992 - 1996年因呼吸原因死亡的婴儿比例相对较少(1983 - 1990年为82.5%;1992 - 1996年为60.0%;优势比(OR)0.31,95%;置信区间(CI)0.16 - 0.57),但因败血症原因死亡的更多(1983 - 1990年为14.3%;1992 - 1996年为43.8%;OR 4.9,95%;CI 2.6 - 9.2)。
随着时间推移死亡率下降,呼吸原因导致的死亡减少,但败血症原因导致的死亡增加。外源性表面活性剂及呼吸支持使用方面的进一步进展可能会降低呼吸死亡。迫切需要有效的策略来减少医院感染。